Harries RL, Bosanquet DC, Harding KG. Wound bed preparation: Time for an update. International Wound Journal. 2016Aug22;13(S3):8–14. doi: 10.1111/iwj.12662
Leaper DJ, Schultz G, Carville K, Fletcher J, Swanson T, Drake R. Extending the time concept: What have we learned in the past 10 years?*. International Wound Journal. 2012Nov12;9(Suppl 2):1–19. https://doi.org/10.1111/j.1742-481X.2012.01097.x
Babalska ZŁ, Korbecka-Paczkowska M, Karpiński TM. Wound antiseptics and European guidelines for antiseptic application in wound treatment. Pharmaceuticals. 2021Dec2;14(12):1253–67. https://doi.org/10.3390/ph14121253
Alves PJ, Barreto RT, Barrois BM, Gryson LG, Meaume S, Monstrey SJ. Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm. International Wound Journal. 2020Dec13;18(3):342–58. DOI:10.1111/iwj.13537
Bigliardi PL, Alsagoff SA, El-Kafrawi HY, Pyon J-K, Wa CT, Villa MA. Povidone iodine in wound healing: A review of current concepts and practices. International Journal of Surgery. 2017Jun23;44:260–8. http://dx.doi.org/10.1016/j.ijsu.2017.06.073
Eggers M. Infectious disease management and control with Povidone Iodine. Infectious Diseases and Therapy. 2019Aug14;8(4):581–93. https://doi.org/10.1007/s40121-019-00260-x
Monstrey SJ, Govaers K, Lejuste P, Lepelletier D, Ribeiro de Oliveira P. Evaluation of the role of povidone-iodine in the prevention of surgical site infections. Surgery Open Science. 2023Mar16;13:9–17. https://doi.org/10.1016/j.sopen.2023.03.005
Lepelletier D, Maillard JY, Pozzetto B, Simon A. Povidone Iodine: Properties, mechanisms of action, and role in infection control and staphylococcus aureus decolonization. Antimicrobial Agents and Chemotherapy. 2020Aug20;64(9). https://doi.org/10.1128/AAC.00682-20
Lachapelle J-M, Castel O, Casado AF, Leroy B, Micali G, Tennstedt D, et al. Antiseptics in the era of bacterial resistance: A focus on Povidone Iodine. Clinical Practice. 2013Sep;10(5):579–92. DOI:10.2217/cpr.13.50
Hoekstra MJ, Westgate SJ, Mueller S. Povidone-iodine ointment demonstrates in vitro efficacy against biofilm formation. International Wound Journal. 2016Mar10;14(1):172–9. doi: 10.1111/iwj.12578
Hosaka Y, Saito A, Maeda R, Fukaya C, Morikawa S, Makino A, et al. Antibacterial activity of povidone–iodine against an artificial biofilm of porphyromonas gingivalis and fusobacterium nucleatum. Archives of Oral Biology. 2012 Apr;57(4):364–8. doi:10.1016/j.archoralbio.2011.09.005
Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF; CLEAN trial investigators. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet. 2015 Nov 21;386(10008):2069-2077.
Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, Palazzo P, Bironneau V, Prevost F, Paul J, Pichon M, Boisson M, Frasca D, Mimoz O; CLEAN-3 trial investigators. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021 Jul;21(7):1038-1048.
Eming SA, Smola-Hess S, Kurschat P, Hirche D, Krieg T, Smola H. A novel property of povidon-iodine: Inhibition of excessive protease levels in chronic non-healing wounds. Journal of Investigative Dermatology. 2006Jul6;126(12):2731–3. doi:10.1038/sj.jid.5700474